Greater decreases in cholesterol levels among individuals with high cardiovascular risk than among the general population: The northern Sweden MONICA study 1994 to 2014

European Heart Journal

Volumn 37, Issue 25, 2016, Pages 1985-1992

  Eriksson, Marie ^a   Forslund, Ann Sofi ^b   Jansson, Jan Hakan ^c   Söderberg, Stefan ^c   Wennberg, Maria ^c   Eliasson, Mats ^c  

^a UMEÅ UNIVERSITY   (Sweden)

^b Norrbotten County Council   (Sweden)

^c UMEÅ UNIVERSITY   (Sweden)

Author keywords

Cardiovascular disease; Cholesterol; Diabetes; Epidemiology; Lipid regulating agents; Obesity; Socioeconomic factors

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; EDUCATION; FEMALE; HEALTH SURVEY; HEART INFARCTION; HIGH RISK POPULATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OBESITY; POPULATION RESEARCH; PRIORITY JOURNAL; SMOKING; SOCIAL STATUS; SWEDEN; CARDIOVASCULAR SYSTEM; MIDDLE AGED; RISK FACTOR;

ADULT; AGED; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; CHOLESTEROL; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SWEDEN;

EID: 84977544714     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehw052     Document Type: Article

References (30)

1. Bjorck L, Capewell S, O'Flaherty M, Lappas G, Bennett K, Rosengren A. Decline in coronary mortality in Sweden between 1986 and 2002: comparing contributions from primary and secondary prevention. PLoS ONE 2015;10:e0124769.
2. Prospective Studies Collaboration, Lewington S, Whitlock G, Clarke R, Sherliker P, Emberson J, Halsey J, Qizilbash N, Peto R, Collins R. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet 2007;370:1829-1839.
3. Fifth Joint Task Force of the European Society of Cardiology, European Association of Echocardiography, European Association of Percutaneous Cardiovascular Interventions, European Heart Rhythm Association, Heart Failure Association, European Association for Cardiovascular Prevention &Rehabilitation, European Atherosclerosis Society, International Society of Behavioural Medicine, European Stroke Organisation, European Society of Hypertension, European Association for the Study of Diabetes, European Society of General Practice/Family Medicine, International Diabetes Federation Europe, European Heart Network. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): the Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur J Prev Cardiol 2012;19:585-667.
4. Farzadfar F, Finucane MM, Danaei G, Pelizzari PM, Cowan MJ, Paciorek CJ, Singh GM, Lin JK, Stevens GA, Riley LM, Ezzati M, Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Cholesterol). National, regional, and global trends in serum total cholesterol since 1980: systematic analysis of health examination surveys and epidemiological studies with 321 country-years and 3.0 million participants. Lancet 2011;377:578-586.
5. Carroll MD, Kit BK, Lacher DA, Shero ST, Mussolino ME. Trends in lipids and lipoproteins in US adults, 1988-2010. J Am Med Assoc 2012;308:1545-1554.
6. Eriksson M, Holmgren L, Janlert U, Jansson JH, Lundblad D, Stegmayr B, Soderberg S, Eliasson M. Large improvements in major cardiovascular risk factors in the population of northern Sweden: the MONICA study 1986-2009. J Intern Med 2011;269:219-231.
7. Ng N, Johnson O, Lindahl B, Norberg M. A reversal of decreasing trends in population cholesterol levels in Vasterbotten County, Sweden. Glob Health Action 2012; 5: doi: 10.3402/gha.v5i0.10367.
8. Capewell S, Ford E. Why have total cholesterol levels declined in most developed countries? BMC Public Health 2011;11:641.
9. Eliasson M, Janlert U, Jansson JH, Stegmayr B. Time trends in population cholesterol levels 1986-2004: influence of lipid-lowering drugs, obesity, smoking and educational level. The northern Sweden MONICA study. J Intern Med 2006;260:551-559.
10. Thorsson B, Steingrimsdottir L, Halldorsdottir S, Andersen K, Sigurdsson G, Aspelund T, Gudnason V. Changes in total cholesterol levels inWestern societies are not related to statin, but rather dietary factors: the example of the Icelandic population. Eur Heart J 2013;34:1778-1782.
11. Johansson I, Nilsson LM, Stegmayr B, Boman K, Hallmans G, Winkvist A. Associations among 25-year trends in diet, cholesterol and BMI from 140,000 observations in men and women in Northern Sweden. Nutr J 2012;11:40-2891-11-40.
12. Lonnberg G. VIP 1990-2014. http://public.tableau.com/views/VHU1990-2014/Kolesterol?:embed=y&:toolbar=no&:loadOrderID=0&:display- count=yes&:showTabs=y (14 July 2015).
13. Krachler B, Eliasson M, Stenlund H, Johansson I, Hallmans G, Lindahl B. Populationwide changes in reported lifestyle are associated with redistribution of adipose tissue. Scand J Public Health 2009;37:545-553.
14. Zethelius B, Eliasson B, Eeg-Olofsson K, Svensson AM, Gudbjornsdottir S, Cederholm J, NDR. A new model for 5-year risk of cardiovascular disease in type 2 diabetes, from the Swedish National Diabetes Register (NDR). Diabetes Res Clin Pract 2011;93:276-284.
15. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360:7-22.
16. Eliasson M, Jansson JH, Lundblad D, Naslund U. The disparity between long-term survival in patients with and without diabetes following a first myocardial infarction did not change between 1989 and 2006: an analysis of 6,776 patients in the Northern Sweden MONICA Study. Diabetologia 2011;54:2538-2543.
17. Egan BM, Li J, Qanungo S,Wolfman TE. Blood pressure and cholesterol control in hypertensive hypercholesterolemic patients: national health and nutrition examination surveys 1988-2010. Circulation 2013;128:29-41.
18. Sever PS, Dahlof B, Poulter NR, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J, ASCOT Investigators. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet 2003;361:1149-1158.
19. Flegal KM, Kit BK, Orpana H, Graubard BI. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA 2013;309:71-82.
20. Benckert M, LiljaM, Soderberg S, Eliasson M. Improved metabolic health among the obese in six population surveys 1986 to 2009: the Northern Sweden MONICA study. BMC Obesity 2015;2:7.
21. Forey BA, Fry JS, Lee PN, Thornton AJ, Coombs KJ. The effect of quitting smoking on HDL-cholesterol - A review based on within-subject changes. Biomark Res 2013; 1:26-7771-1-26.
22. Kotseva K, Wood D, De Backer G, De Bacquer D, Pyorala K, Keil U, EUROASPIRE Study Group. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet 2009;373:929-940.
23. Hambraeus K, Tyden P, Lindahl B. Time trends and gender differences in prevention guideline adherence and outcome after myocardial infarction: data from the SWEDEHEART registry. Eur J Prev Cardiol 2016;23:340-348.
24. Glader EL, Sjolander M, Eriksson M, Lundberg M. Persistent use of secondary preventive drugs declines rapidly during the first 2 years after stroke. Stroke 2010;41: 397-401.
25. Rosengren A, Subramanian SV, Islam S, Chow CK, Avezum A, Kazmi K, Sliwa K, Zubaid M, Rangarajan S, Yusuf S, INTERHEART Investigators. Education and risk for acute myocardial infarction in 52 high, middle and low-income countries: INTERHEART case-control study. Heart 2009;95:2014-2022.
26. Ferrario MM, Veronesi G, Chambless LE, Tunstall-Pedoe H, Kuulasmaa K, Salomaa V, Borglykke A, Hart N, Soderberg S, Cesana G, MORGAM Project. The contribution of educational class in improving accuracy of cardiovascular risk prediction across European regions: the MORGAM Project Cohort Component. Heart 2014;100:1179-1187.
27. Kanjilal S, Gregg EW, Cheng YJ, Zhang P, Nelson DE, Mensah G, Beckles GL. Socioeconomic status and trends in disparities in 4 major risk factors for cardiovascular disease among US adults, 1971-2002. Arch Intern Med 2006;166: 2348-2355.
28. Ernstsen L, Strand BH, Nilsen SM, Espnes GA, Krokstad S. Trends in absolute and relative educational inequalities in four modifiable ischaemic heart disease risk factors: repeated cross-sectional surveys from the Nord-Trondelag Health Study (HUNT) 1984-2008. BMC Public Health 2012;12:266-2458-12-266.
29. Eggen AE, Mathiesen EB, Wilsgaard T, Jacobsen BK, Njolstad I. Trends in cardiovascular risk factors across levels of education in a general population: is the educational gap increasing? The Tromso study 1994-2008. J Epidemiol Community Health 2014;68:712-719.
30. Paalanen L, Prattala R, Laatikainen T. Contribution of education level and dairy fat sources to serum cholesterol in Russian and Finnish Karelia: results from four cross-sectional risk factor surveys in 1992-2007. BMC Public Health 2012;12: 910-2458-12-910.